Page last updated: 2024-11-08

aspartimide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

aspartimide: formed under acid or basic conditions in the synthesis of aspartic acid-containing peptides [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID188987
CHEBI ID195552
SCHEMBL ID48364
MeSH IDM0204241

Synonyms (14)

Synonym
aspartimide
2,5-pyrrolidinedione, 3-amino-
CHEBI:195552
5615-80-5
aminosuccinimide
3-aminopyrrolidine-2,5-dione
alpha-aminosuccinimide
SCHEMBL48364
YDNMHDRXNOHCJH-UHFFFAOYSA-N
tetrahydropyrrole-3-amino-2,5-dione
AT18952
DTXSID80900978
noname_24
EN300-123790
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
Maillard reaction productAny thermal degradation product obtained as a result of a chemical reaction between an amino acid and a reducing sugar (Maillard reaction, a non-enzymatic browning procedure that usually imparts flavour to starch-based food products).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
dicarboximideAn imide in which the two acyl substituents on nitrogen are carboacyl groups.
primary amino compoundA compound formally derived from ammonia by replacing one hydrogen atom by an organyl group.
pyrrolidinone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (2.63)18.7374
1990's4 (10.53)18.2507
2000's15 (39.47)29.6817
2010's14 (36.84)24.3611
2020's4 (10.53)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.78 (24.57)
Research Supply Index3.69 (2.92)
Research Growth Index5.24 (4.65)
Search Engine Demand Index52.05 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (2.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other38 (97.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]